CereSync

Curated by Signal

AI-powered assessment tools in treating dementia

Overview

AI-powered assessment tools in treating dementia. The company focuses on enhancing diagnostic accuracy and personalized care for individuals affected by dementia.

Key facts

Founded: 2023
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

ANMODE Health
Online pharmacy offering alternative medical products
Health TechnologyLos Angeles, United States
Banedi
Digital health assessment tool for child neuropsychological analysis
Health TechnologyUnited States
Aptatek Biosciences
Developer of a medical device for monitoring patients with phenylketonuria
Health TechnologyDelaware, United States

About CereSync

What does CereSync do?

AI-powered assessment tools in treating dementia.

Where is CereSync headquartered?

CereSync is headquartered in New York City, United States.

When was CereSync founded?

CereSync was founded in 2023.

Which sector is CereSync in?

CereSync operates in Health Technology.

Who are CereSync's competitors?

Companies similar to CereSync include ANMODE Health, Banedi, and Aptatek Biosciences.